melasma treatment ❚ with lasers & lights

❚
❚
❚
❚
DNA Repair Practice Management Fine Lines & Wrinkles Patient Wellbeing Industry News
❙
❙
September 2013 Volume 3 Issue 6
September 2013
Volume 3 Issue 6
INTERNATIONAL JOURNAL OF AESTHETIC AND ANTI-AGEING MEDICINE
❙
INTERNATIONAL JOURNAL OF AESTHETIC AND ANTI-AGEING MEDICINE
Stromal
enriched
lipograft
technique and
benefits
Mentoplasty
with alloplastic
implants
Mini-lift
blepharoplasty
avoiding complications
prime-journal.com
melasma
treatment
with lasers & lights
| GUEST EDITORIAL
International Journal of Aesthetic
and Anti-Ageing Medicine
119 Farringdon Road, London,
EC1R 3DA, UK
www.informahealthcare.com
ISSN 2159-8908 (print)
ISSN 2159-8916 (online)
Managing Editor Rosalind Hill
rosalind.hill@informa.com
Sub-Editor Balraj Juttla
balraj.juttla@informa.com
Publisher Mark Eaton
mark.eaton@informa.com / +44(0)20 7017 4060
European Sales Manager Mat Eaton
mat.eaton@informa.com / +44(0)20 7017 4315
Business Development Manager NA Meg McNeel
meg.mcneel@informausa.com / +1 (212) 520 2745
Marketing Manager Jonathan Lissemore
jonathan.lissemore@informa.com
Marketing Director Justin Bambridge
justin.bambridge@informa.com
Production Manager Jonathan Collard
jonathan.collard@informa.com
Graphic Designer Snehal Sanghani
snehal.sanghani@informa.com
Director of Audience Development Nora Pastenkos
nora.pastenkos@informausa.com
Managing Director James Gareh
james.gareh@informa.com
Art Director David ‘Spike’ McCormack
spike@spikedesigns.co.uk
Production & Ads Department primeadverts@informa.com
Please send your manuscripts and press releases to:
rosalind.hill@informa.com
All submitted manuscripts are evaluated on the basis
of scientific quality, originality, appropriateness,
contribution to the field and style. Suitable
manuscripts are subject to peer-review. Manuscripts
and accompanying files should be prepared in
accordance with our Author Guidelines, which are
available via www.prime-journal.com.
All content © 2013 Informa UK Ltd
Images © Shutterstock.com, unless otherwise stated
For address changes, please contact Nora Pastenkos:
nora.pastenkos@informausa.com
W
HY HAVE AESTHETIC TREATMENTS BECOME MORE POPULAR THAN
ever? Despite the economic crisis? Despite the bad examples featured in the
press every day? For an answer, we must look to our patients, as without
them the whole story would not exist.
Despite the economic climate in Europe, aesthetic treatments are more
popular than ever. Leonard Lauder, Chairman of the Board of Estée Lauder,
saw the emergence of this phenomena and looking at his industry during the early 2000s, coined
the phrase ‘lipstick index’, claiming that ‘lipstick sales could be an economic indicator, in that
purchases of cosmetics — lipsticks in particular — tend to inversely correlate to economic health’.
Being a dermatologist practicing both medical dermatology and aesthetic dermatology for many
years now, I have been aware of this trend myself: the wish and desire to look and feel good is crisis
resistant. Looking at the medical aesthetic market, the ‘little’ difference here simply and notably is,
that an aesthetic treatment can’t and certainly shouldn’t be ‘shopped’.
Patients — and I call them patients rather than clients or consumers — don’t necessarily want to look
much younger, but rather refreshed, relaxed, and natural. They want to simply look better, not to
change much, but are looking for discreet results instead. This is certainly a different challenge for
doctors in Europe having a largely Caucasian patient base compared with patients of Asian descent.
The aesthetic toolbox of the medical doctor is huge. From my perspective, non- and
microinvasive interventions are still the most popular choices. The challenge here is a balancing act
between effectiveness and a low downtime profile. The most important duty of any doctor is, and
must be, to reliably and knowledgeably consult with the patient to find ‘the point of change’ in every
patient. The point which would make the optimal improvement once fixed.
The mainstays in the physician’s armamentarium are still well approved and researched
therapies such as botulinum toxin and fillers. However, I am also very keen to look at new products
and new technologies at a basic and clinical research level, as I understand that they may make it to
the market in the future, as the ‘work horses’ of today — toxins and fillers — did in the past.
Unfortunately, quite a few technologies are thrown to the market too quickly, and in an immature
state. A technology may sound intelligent, but the outcomes, complexity of procedures, and
downtime profile may not match the needs or expectations of patients and physicians. I am a great
believer in simple, easy, and cost-effective treatments, such as individually designed chemical peels.
Ultimately — and this is what makes me tick — all of these considerations and concerns relate back
to patient safety. The most important factors in the aesthetic field are training and medical
education. Furthermore, physicians must have or develop the ability to determine the right
treatment choices for patients. In other words, we must distinguish the good therapies from the bad.
It’s all about customising our treatments and finding the appropriate one for the patient.
As long as we try to handle the aesthetic concerns of our patients around the world accordingly,
one does not have to feel shy about accepting a little help to turn back the clock!
Sabine Zenker, MD
Dermatologist, Germany
PRIME JOURNAL EDITORIAL BOARD
BOARD MEMBER
SPECIALISM
COUNTRY
BOARD MEMBER
Dr Claude Dalle
Dr Wilmar Accursio
Dr Ashraf Badawi
Dr Janethy Balakrishnan
Dr Lakhdar Belhaouari
Dr Anthony Benedetto
Dr Philippe Berros Dr Dario Bertossi Dr Pierre Bouhanna
Dr Fahd Benslimane
Prof Wayne Carey
Dr Claude Chauchard
Dr Christophe de Jaeger
Dr Jacques Dequesne
Prof Ilaria Ghersetich
Dr Kate Goldie
Dr Monika Golkova
Prof Eckart Haneke
Dr Steven Hopping
Prof Andreas Katsambas
Dr Mario Krause
Dr David Lai
Dr Marina Landau
Anti-ageing & aesth. medicine
Endocrinology
Dermatology
Aesthetic & anti-ageing medicine
Plastic surgery
Cosmetic Dermatology
Oculoplastic surgery
Maxillofacial surgery
Dermatology – Hair surgery
Plastic Surgery
Dermatology
Anti-ageing medicine
Geriatrics
Gynaecology
Dermatology
Aesthetic Physician
Neurology
Dermatology
Plastic surgery
Dermatology
Anti-ageing medicine
Anti-ageing medicine
Dermatology
France
Brazil
Egypt & Canada
Malaysia
France
USA
Monaco
Italy
France
Morocco
Canada
France
France
France
Italy
UK
Czech Republic
Germany
USA
Greece
Germany
Hong Kong
Israel
Dr Gustavo Leibaschoff
Cosmetic Surgery
Dr Sohail Mansoor
Dermatology
Prof Leonardo Marini
Dermatology
Dr Sly Nedic
Aesthetic & anti-ageing medicine
Prof Dr Martino Neumann
Dermatology & Venereology
Prof Daniel Pella
Cardiology
Dr Chariya Petchngaovilai
Dermatology
Prof Ascanio Polimeni
Neuro-endocrinology
Dr Herve Raspaldo
Facial plastic surgery
Dr Christopher Rowland-PayneDermatology
Dr Neil Sadick
Dermatology
Dr Hema Sundaram
Dermatology
Dr Pakpilai Thavisin
Dermatology & Anti-ageing medicine
Dr Patrick Treacy
Aesthetic surgery
Dr Mario Trelles
Plastic surgery
Dr Ines Verner
Dermatology
Dr Octavio Viera
Anti-ageing medicine
Dr Jean-Luc Vigneron
Aesthetic dermatology
Prof Bernard Weber
Genetics
Dr Sabine Zenker
Dermatology
Catherine Decuyper
Industry expert & consultant
Wendy Lewis
Industry expert
Christophe Luino
Industry expert & consultant
SPECIALISM
COUNTRY
USA
UK
Italy
South Africa
Netherlands
Slovakia
Thailand
Italy
France
UK
USA
USA
Thailand
Ireland
Spain
Israel
Spain
France
Luxembourg
Germany
France
USA
France
prime-journal.com | September 2013
5